tm logo

Monitor this mark

View On USPTO

MEI PHARMA
Live/Registered
REGISTERED AND RENEWED

on 05 Nov 2024

Last Applicant/ Owned by

MEI Pharma Inc.

11455 El Camino Real, Suite 250

San Diego

CA

92130

Serial Number

85575487 filed on 21st Mar 2012

Registration Number

4459693 registered on 31st Dec 2013

in the Principal Register

Correspondent Address

Aaron D. Hendelman

Aaron D. Hendelman WILSON SONSINI GOODRICH & ROSATI

Palo Alto, CA 94304-1050

United States

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

MEI PHARMA

Pharmaceuticals for use in the treatment of oncological disorders, neurological disorders, and immune-related disorders

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceuticals for use in the treatment of oncological disorders, neurological disorders, and immune-related disorders

First Use Date in General

02th Jul 2012

First Use Date in Commerce

29th May 2013

Mark Details

Serial Number

No 85575487

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 40082-TM1002

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
05th Nov 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
05th Nov 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
05th Nov 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
23rd Oct 2024TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
23rd Apr 2024POST REGISTRATION ACTION MAILED - SEC. 8 & 9
23rd Apr 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
20th Dec 2023TEAS SECTION 8 & 9 RECEIVED
31st Dec 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
04th Oct 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04th Oct 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED